Sally C. Medley

Array ( [id] => 4236354 [patent_doc_number] => 06090623 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Recombinant human calcium channel .beta..sub.4 subunits' [patent_app_type] => 1 [patent_app_number] => 8/949386 [patent_app_country] => US [patent_app_date] => 1997-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 114983 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090623.pdf [firstpage_image] =>[orig_patent_app_number] => 949386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105749 [patent_doc_number] => 06051689 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Receptor for the glucagon-like-peptide (GLP-1)' [patent_app_type] => 1 [patent_app_number] => 8/935317 [patent_app_country] => US [patent_app_date] => 1997-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12205 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051689.pdf [firstpage_image] =>[orig_patent_app_number] => 935317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949903 [patent_doc_number] => 05977334 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'DNA encoding a chemokine, Beta R1, comprising the Beta R1 promoter' [patent_app_type] => 1 [patent_app_number] => 8/927722 [patent_app_country] => US [patent_app_date] => 1997-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 7366 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977334.pdf [firstpage_image] =>[orig_patent_app_number] => 927722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4192785 [patent_doc_number] => 06013253 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Treatment of multiple sclerosis using consensus interferon and IL-1 receptor antagonist' [patent_app_type] => 1 [patent_app_number] => 8/911893 [patent_app_country] => US [patent_app_date] => 1997-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4338 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013253.pdf [firstpage_image] =>[orig_patent_app_number] => 911893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4133540 [patent_doc_number] => 06015552 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Use of nerve growth factor-2 (NGF-2) /neurotrophin-3 (NT-3) to promote leukocyte proliferation' [patent_app_type] => 1 [patent_app_number] => 8/910691 [patent_app_country] => US [patent_app_date] => 1997-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 25 [patent_no_of_words] => 11511 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015552.pdf [firstpage_image] =>[orig_patent_app_number] => 910691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3922788 [patent_doc_number] => 05914253 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-22 [patent_title] => 'Recombinant production of murine interferon--.gamma. (IFN-.gamma.) inducing factor (IGIF, IL-18)' [patent_app_type] => 1 [patent_app_number] => 8/908005 [patent_app_country] => US [patent_app_date] => 1997-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 16279 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/914/05914253.pdf [firstpage_image] =>[orig_patent_app_number] => 908005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177664 [patent_doc_number] => 06159461 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Use of c-kit ligand with TNF-.alpha. and hematopoietic factors for the expansion or differentiation of hematopoietic cells' [patent_app_type] => 1 [patent_app_number] => 8/898982 [patent_app_country] => US [patent_app_date] => 1997-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 65 [patent_no_of_words] => 37512 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159461.pdf [firstpage_image] =>[orig_patent_app_number] => 898982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4138119 [patent_doc_number] => 06060283 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Genomic DNA encoding human interleukin-18 (IL-18, interferon-.gamma. inducing factor)' [patent_app_type] => 1 [patent_app_number] => 8/884324 [patent_app_country] => US [patent_app_date] => 1997-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20184 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060283.pdf [firstpage_image] =>[orig_patent_app_number] => 884324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3834915 [patent_doc_number] => 05846747 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Method for detecting glucagon-like peptide-1 antagonists and agonists' [patent_app_type] => 1 [patent_app_number] => 8/869477 [patent_app_country] => US [patent_app_date] => 1997-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8052 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846747.pdf [firstpage_image] =>[orig_patent_app_number] => 869477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4263020 [patent_doc_number] => 06258944 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'OB receptor isoforms and nucleic acids encoding them' [patent_app_type] => 1 [patent_app_number] => 8/827962 [patent_app_country] => US [patent_app_date] => 1997-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10830 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258944.pdf [firstpage_image] =>[orig_patent_app_number] => 827962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3758255 [patent_doc_number] => 05843726 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Expression of a cleavable fusion protein comprising a soluble human erythropoietin receptor protein fragment' [patent_app_type] => 1 [patent_app_number] => 8/850293 [patent_app_country] => US [patent_app_date] => 1997-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 7859 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843726.pdf [firstpage_image] =>[orig_patent_app_number] => 850293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4171370 [patent_doc_number] => 06083724 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Recombinant avian interferon-gamma (IFN-.gamma.)' [patent_app_type] => 1 [patent_app_number] => 8/765381 [patent_app_country] => US [patent_app_date] => 1997-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 59 [patent_no_of_words] => 24119 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083724.pdf [firstpage_image] =>[orig_patent_app_number] => 765381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4207891 [patent_doc_number] => 06077949 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Cloned glucagon-like peptide 2 receptors' [patent_app_type] => 1 [patent_app_number] => 8/845546 [patent_app_country] => US [patent_app_date] => 1997-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17080 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077949.pdf [firstpage_image] =>[orig_patent_app_number] => 845546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4184861 [patent_doc_number] => 06020465 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Recombinant avian type i interferon' [patent_app_type] => 1 [patent_app_number] => 8/831627 [patent_app_country] => US [patent_app_date] => 1997-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6731 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020465.pdf [firstpage_image] =>[orig_patent_app_number] => 831627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4006933 [patent_doc_number] => 05962260 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Recombinant production of human and bovine receptors for modified low-density lipoprotein' [patent_app_type] => 1 [patent_app_number] => 8/809494 [patent_app_country] => US [patent_app_date] => 1997-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10948 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962260.pdf [firstpage_image] =>[orig_patent_app_number] => 809494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4100875 [patent_doc_number] => 06048971 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Recombinant human erythropoietin mutants' [patent_app_type] => 1 [patent_app_number] => 8/808881 [patent_app_country] => US [patent_app_date] => 1997-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11562 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048971.pdf [firstpage_image] =>[orig_patent_app_number] => 808881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3880756 [patent_doc_number] => 05798228 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-25 [patent_title] => 'Recombinant production of dog and horse type I interferons' [patent_app_type] => 1 [patent_app_number] => 8/805165 [patent_app_country] => US [patent_app_date] => 1997-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 74 [patent_no_of_words] => 24508 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/798/05798228.pdf [firstpage_image] =>[orig_patent_app_number] => 805165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998794 [patent_doc_number] => 05858712 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'CDNA encoding a LEA-motif developmental protein homologous to avian px19' [patent_app_type] => 1 [patent_app_number] => 8/796676 [patent_app_country] => US [patent_app_date] => 1997-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 17371 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858712.pdf [firstpage_image] =>[orig_patent_app_number] => 796676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1558456 [patent_doc_number] => 06436391 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Use of interferon (IFN)-8 and -14 as vaccine adjuvants' [patent_app_type] => B1 [patent_app_number] => 08/897235 [patent_app_country] => US [patent_app_date] => 1997-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 880 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436391.pdf [firstpage_image] =>[orig_patent_app_number] => 08897235 [rel_patent_id] =>[rel_patent_doc_number] =>)